Pharma IQ: How has the global serialisation landscape evolved in recent years?
P Kemppainen: It has gotten more complicated after the introduction of first markets, like China, Turkey and now Korea, and it’s evolving, unfortunately, in the same direction. Basically all the markets requiring serialisation are have diversified and have different expectations and requirements.
I would say that from the pharma manufacturer point of view, the challenge is that how do you keep...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More